As CaMKK2 levels are up-regulated in DMD patients, CaMKK2 inhibition maybe serve as a potential target to maintain skeletal muscle functions and provide a therapeutic strategy to treat patients with muscle injury or severe myopathies. Here, CAMKK2 is linked to Duchenne muscular dystrophy.